Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Marsico

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Nucleic Acids Research|July 30, 2015
Identification of siRNA delivery enhancers by a chemical library screenJerome Gilleron, Prasath Paramasivam, Anja Zeigerer, et al.
Journal of Human Genetics|October 14, 2016
Clinical evaluation and molecular screening of a large consecutive series of albino patientsLucia Mauri, Emanuela Manfredini, Alessandra Del Longo, et al.
NPJ Precision Oncology|February 3, 2026
Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patientsSusanne Flach, Christodoulos Pipinikas, Tom Huberty, et al.
Nature Biotechnology|June 25, 2013
Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escapeJerome Gilleron, William Querbes, Anja Zeigerer, et al.
Cell Reports|May 5, 2015
Regulation of liver metabolism by the endosomal GTPase Rab5Anja Zeigerer, Roman L Bogorad, Kirti Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast CancerMarla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos, et al.
Journal of Medicinal Chemistry|January 23, 2018
Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small MoleculeChiara Marchetti, Katherine G Zyner, Stephan A Ohnmacht, et al.
Nature Medicine|July 17, 2023
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trialJeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann, et al.
Nature Medicine|February 2, 2023
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trialJeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|November 18, 2009
III Brazilian Thoracic Association Guidelines on tuberculosisMarcus Barreto Conde, Fernando Augusto Fiuza de Melo, Ana Maria Campos Marques, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Nucleic Acids Research|July 30, 2015
Identification of siRNA delivery enhancers by a chemical library screenJerome Gilleron, Prasath Paramasivam, Anja Zeigerer, et al.
Journal of Human Genetics|October 14, 2016
Clinical evaluation and molecular screening of a large consecutive series of albino patientsLucia Mauri, Emanuela Manfredini, Alessandra Del Longo, et al.
NPJ Precision Oncology|February 3, 2026
Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patientsSusanne Flach, Christodoulos Pipinikas, Tom Huberty, et al.
Nature Biotechnology|June 25, 2013
Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escapeJerome Gilleron, William Querbes, Anja Zeigerer, et al.
Cell Reports|May 5, 2015
Regulation of liver metabolism by the endosomal GTPase Rab5Anja Zeigerer, Roman L Bogorad, Kirti Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast CancerMarla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos, et al.
Journal of Medicinal Chemistry|January 23, 2018
Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small MoleculeChiara Marchetti, Katherine G Zyner, Stephan A Ohnmacht, et al.
Nature Medicine|July 17, 2023
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trialJeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann, et al.
Nature Medicine|February 2, 2023
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trialJeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|November 18, 2009
III Brazilian Thoracic Association Guidelines on tuberculosisMarcus Barreto Conde, Fernando Augusto Fiuza de Melo, Ana Maria Campos Marques, et al.
Pageof 4